Approximately 14% of all strokes occur during sleep, preventing many from getting clot-busting treatment, according to a study published in the 10 May 2011, print issue of Neurology, the medical journal of the American Academy of Neurology.
“Because the only treatment for ischaemic stroke must be given within a few hours after the first symptoms begin, people who wake up with stroke symptoms often cannot receive the treatment since we cannot determine when the symptoms started,” said study author Jason Mackey, member of the American Academy of Neurology. “Imaging studies are being conducted now to help us develop better methods to identify which people are most likely to benefit from the treatment, even if symptoms started during the night.”
The study examined all cases of ischaemic stroke in people age 18 and older seen in hospital emergency departments in the Greater Cincinnati/Northern Kentucky region in the USA, over one year. The majority of strokes are ischaemic strokes caused by blocked blood flow in the brain.
Of the 1,854 ischaemic strokes in the study, 14% (273) were “wake-up strokes,” where the person woke up with stroke symptoms. By extrapolating that number to the general US population, the researchers estimate that approximately 58,000 people in the United States go to the emergency department with a wake-up stroke in a year.
The researchers compared those with wake-up strokes to those who were awake when their stroke symptoms started. There were no differences between the two groups in terms of sex, whether they were married or were living with someone, and their stroke risk factors such as high blood pressure, diabetes, smoking or high cholesterol.
There were minor statistically significant differences in age and the severity of the stroke. People with wake-up strokes were an average of 72 years old, compared to 70 for non-wake-up strokes. Those with wake-up strokes had an average score of four on a test of stroke severity, compared to a three for those with non-wake-up strokes. Scores ranging from one to four indicate mild strokes.
The researchers also analysed whether those with wake-up strokes would have been eligible for the clot-busting drug tissue plasminogen activator (tPA), if the time of stroke onset had been available. Of the 273 wake-up strokes, at least 98 would have been eligible for treatment.
“This is a group of patients that should be a focus for future studies,” Mackey said. “It is likely that some of these strokes occurred immediately prior to awakening, and people would benefit from treatment.”
